Numbify Sanitize
Product Images NDC 69804-087

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Numbify Sanitize (NDC 69804-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ridge Properties, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
This text provides directions for how to use a spray medication to treat an affected area of the body. It advises adults and children over 2 years old to clean the area and apply the spray 1-3 times daily, which can then be covered with a sterile bandage. However, it warns against using the spray on children under 2 years old without consulting a doctor first.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients Section)

Inactive Ingredients (Inactive Ingredients Section)
This is a description of the inactive ingredients in a product. The product contains propylene glycol, water, and kava. Additionally, it contains acrylates C10-30 alkyl acrylate crosspolymer. The product's active ingredient and purpose are not specified in the provided text.*
FDA Label Image

Indications And Usage (Indications And Usage)

FDA Label Image

Active Ingredients (Otc Active Ingredients Section)

Active Ingredients (Otc Active Ingredients Section)
This is a description of the active ingredients and their purposes. The product contains Benzalkonium Chloride at 0.13% which is used as a first aid antiseptic. Additionally, it contains 4% Lidocaine HCL which provides temporary relief of pain and itching.*
FDA Label Image

Purpose (Otc Purpose Section)

Purpose (Otc Purpose Section)
This is a description of the active ingredients and their purposes in a medication. The medication contains 0.13% benzalkonium chloride and 4% lidocaine HCL. Benzalkonium chloride is used as a first aid antiseptic, while lidocaine HCL provides temporary relief of pain and itching.*
FDA Label Image

Keep Out Of Reach Of Children (Otc Keep Out Of Reach Of Children Section)

Keep Out Of Reach Of Children (Otc Keep Out Of Reach Of Children Section)
The text provides a warning for the use of a product, advising to keep out of reach of children, for external use only, and not for use around the eyes. If ingested, it recommends seeking medical help or calling a poison control center immediately. The user is advised to stop using the product if skin becomes irritated, the condition worsens or if symptoms last longer than 7 days. Additionally, if symptoms clear up and then return within a few days, it is recommended to consult a doctor.*
FDA Label Image

Warnings (Warnings Section)

Warnings (Warnings Section)
This text is a warning for the usage of a product. It cautions the reader to keep it out of reach of children, to use it externally only, and not to use it around the eyes. In case of ingestion, medical help should be sought immediately or a poison control center should be called. The user should stop using the product and contact a doctor if the skin becomes irritated, the condition worsens, the symptoms last longer than 7 days, or if symptoms clear up and then return within a few days.*
FDA Label Image

Principal Display Panel (Principal Display Panel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.